| 常用名 | 瑞卢戈利 | CAS号 | 737789-87-6 |
|---|---|---|---|
| 价格 | ¥需询单/1g | 纯度 | 98.0% |
| 备货期 | 1天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Relugolix is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist with IC50 of 0.33 nM in the presence of 40% fetal bovine serum, TAK-385 possesses higher affinity and potent antagonistic activity compared with TAK-013.target: GnRH [1]IC50: 0.33 nM [1]In vivo: In female knock-in mice, twice-daily oral administration of TAK-385 (100mg/kg) induces constant diestrous phases within the first week, decreases the uterus weight to ovariectomized levels and downregulated GnRH receptor mRNA in the pituitary after 4 weeks.[2] 物理化学性质: CAS号:737789-87-6 常用中文名:瑞卢戈利 常用英文名:Relugolix 分子式:C29H27F2N7O5S 分子量:623.63 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8℃ |